FGF21 and metabolic syndrome: FGF-21 has been demonstrated to physiologically modulate gluconeogenesis and lipolysis in the liver and adipose tissues during fasting and starvation after binding to its receptor and forming a complex with β-klotho; furthermore, studies have shown that administration of FGF-21 reduced body weight, dyslipidemia, and insulin sensitivity [8,9].